Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$67.31 - $124.76 $348,935 - $646,755
5,184 Added 17.26%
35,211 $3.4 Million
Q3 2023

Nov 14, 2023

BUY
$102.5 - $123.59 $711,657 - $858,085
6,943 Added 30.08%
30,027 $3.64 Million
Q2 2023

Aug 14, 2023

BUY
$106.4 - $157.19 $941,427 - $1.39 Million
8,848 Added 62.15%
23,084 $2.64 Million
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $681,556 - $904,586
5,799 Added 68.73%
14,236 $1.96 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $850,955 - $1.11 Million
8,437 New
8,437 $1.09 Million
Q1 2021

May 14, 2021

SELL
$72.25 - $168.95 $705,738 - $1.65 Million
-9,768 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $534,885 - $761,432
-4,260 Reduced 30.37%
9,768 $1.67 Million
Q3 2020

Nov 16, 2020

BUY
$127.12 - $172.34 $47,415 - $64,282
373 Added 2.73%
14,028 $1.97 Million
Q2 2020

Aug 14, 2020

BUY
$93.0 - $171.7 $46,593 - $86,021
501 Added 3.81%
13,655 $2.19 Million
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $383,396 - $612,652
4,654 Added 54.75%
13,154 $1.29 Million
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $38,265 - $67,790
500 Added 6.25%
8,500 $1.1 Million
Q3 2019

Nov 14, 2019

BUY
$72.81 - $156.91 $218,430 - $470,730
3,000 Added 60.0%
8,000 $603,000
Q2 2019

Aug 14, 2019

SELL
$112.21 - $151.95 $336,630 - $455,849
-3,000 Reduced 37.5%
5,000 $760,000
Q1 2019

May 15, 2019

SELL
$106.67 - $151.68 $1.01 Million - $1.44 Million
-9,500 Reduced 54.29%
8,000 $954,000
Q4 2018

Feb 14, 2019

SELL
$97.32 - $148.76 $2.19 Million - $3.35 Million
-22,500 Reduced 56.25%
17,500 $1.91 Million
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $2.65 Million - $3.71 Million
-23,000 Reduced 36.51%
40,000 $6.46 Million
Q2 2018

Aug 14, 2018

SELL
$71.74 - $153.69 $107,609 - $230,535
-1,500 Reduced 2.33%
63,000 $8.33 Million
Q1 2018

May 15, 2018

SELL
$54.02 - $82.27 $2.46 Million - $3.74 Million
-45,500 Reduced 41.36%
64,500 $4.78 Million
Q4 2017

Feb 14, 2018

SELL
$47.64 - $56.75 $524,040 - $624,250
-11,000 Reduced 9.09%
110,000 $6.12 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $4.32 Million - $5.71 Million
121,000
121,000 $5.49 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $8.73B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.